Showing results (101-110 of 238) with videos related to
Sort By:
Pageof 24
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92)Peter H Wiernik, Janice P Dutcher, Xiapan Yao, et al.Haematologica|April 23, 2010
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphomaEldad J Dann, Rachel Bar-Shalom, Ada Tamir, et al.Cancer|January 19, 2012
A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphomaAvichai Shimoni, Irit Avivi, Jacob M Rowe, et al.British Journal of Haematology|December 25, 2024
CPX-351 +/- gemtuzumab ozogamicin as induction therapy for adult patients with newly diagnosed, favourable-intermediate risk, FLT3-ITD negative, AML: A pilot studyChezi Ganzel, Avraham Frisch, Ofir Wolach, et al.Leukemia & Lymphoma|June 2, 2020
A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemiaStephen A Strickland, Xin Victoria Wang, Jan Cerny, et al.Cancer|July 15, 2010
Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology GroupJacob M Rowe, Haesook T Kim, Peter A Cassileth, et al.Experimental Hematology|February 6, 2014
Single cell analysis exposes intratumor heterogeneity and suggests that FLT3-ITD is a late event in leukemogenesisRoni Shouval, Liran I Shlush, Shlomit Yehudai-Resheff, et al.Blood|April 19, 2012
An activating intragenic deletion in NOTCH1 in human T-ALLJ Erika Haydu, Kim De Keersmaecker, Mary Kaye Duff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2004
Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology GroupMartin S Tallman, Haesook T Kim, Elisabeth Paietta, et al.Experimental Hematology|December 24, 2021
Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatmentAriella Tvito, Aaron Ronson, Renan Ghosheh, et al.Pageof 24